Publications by authors named "Bozhena Saar-Ryss"

Claim this Profile
R
Risk of adverse pregnancy outcomes after abnormal hysterosalpingography.
Erika Gandelsman, Leonti Grin, Tamar Wainstock, Roza Berkovitz Shperling, Elena Scherbina, Bozhena Saar-Ryss

Hum Fertil (Camb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency.
Leonti Grin, Roza Berkovitz-Shperling, Gal Goldstein, Yulia Michailov, Ofer Gemer, Bozhena Saar-Ryss

F S Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome using the Q300™ device in a reproductive laboratory environment: an open-label, non-controlled and non-randomized study.
Yulia Michailov, Eden Amsalem, Natalia Umanski, Valeria Tamadaev, Shevach Friedler, Bozhena Saar-Ryss

Reprod Biol Endocrinol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Aspects of Postmortem Sperm Procurement: What Do We Actually Know?
Shevach Friedler, Bozhena Saar-Ryss, Myriam Safrai

Isr Med Assoc J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First clinical pregnancy and delivery achieved after using a new 3D imaging technology for sperm selection: a case report.
Yulia Michailov, Shevach Friedler, Bozhena Saar-Ryss

Front Reprod Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there any truth in the myth that IVF treatments involve weight gain?
Bozhena Saar-Ryss, Michael Shilo, Michael Friger, Leonti Grin, Yulia Michailov

Front Reprod Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stain-Free Sperm Analysis and Selection for Intracytoplasmic Sperm Injection Complying with WHO Strict Normal Criteria.
Yulia Michailov, Luba Nemerovsky, Yehudith Ghetler, Maya Finkelstein, Oshrat Schonberger, Bozhena Saar-Ryss

Biomedicines· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU.
Raoul Orvieto, Adva Aizer, Bozhena Saar-Ryss, Lilach Marom-Haham, Meirav Noach-Hirsh

Reprod Biol Endocrinol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Ofer Gemer, Ofer Lavie, Michael Gdalevich, Ram Eitan, Ela Mamanov, Bozhena Saar-Ryss

Am J Clin Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgery.
Ofer Gemer, Ram Eitan, Michael Gdalevich, Ala Mamanov, Benjamin Piura, Bozhena Saar-Ryss

Int J Gynecol Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization-embryo transfer cycles?
Raoul Orvieto, Bozhena Saar-Ryss, Giuseppe Morgante, Ofer Gemer, Eyal Y Anteby

Fertil Steril· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis